In Vitro & In Vivo Diagnostic Substances
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 1.46M | $1.0M | 12.09% | -- | 2026-06-30 |
| LUMINUS MANAGEMENT LLC | 156.9K | -- | 1.30% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 55.5K | -- | 0.46% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 50.7K | -- | 0.42% | -- | 2026-06-30 |
| Wealthspire Advisors, LLC | 45.0K | -- | 0.37% | -- | 2026-06-30 |
| STATE STREET CORP | 34.0K | -- | 0.28% | -- | 2026-06-30 |
| XTX Topco Ltd | 25.4K | -- | 0.21% | -- | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 25.1K | -- | 0.21% | -- | 2026-06-30 |
| BlackRock, Inc. | 22.3K | -- | 0.19% | -- | 2026-06-30 |
| NORTHERN TRUST CORP | 13.0K | -- | 0.11% | -- | 2026-06-30 |
